Lengo Therapeutics has been acquired by Blueprint Medicines. Follow @Blueprint Medicines and visit the Blueprint Medicines website to learn more: https://www.blueprintmedicines.com/
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for children and adults living with rare and serious disease.